MSON News and Press, MISONIX Inc. From 09/17/21

NEW YORK, NY / ACCESSWIRE / September 17, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: BayCom Corp (NASDAQ:BCML) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relat...

Sanofi makes a second purchase just six weeks after its $2 billion deal for Translate Bio. Potential deal in the works, Columbia Property Trust comes to fruition. Macquarie Infrastructure Partners completes the acquisition of Cincinnati Bell. For further details see: Mer...

FARMINGDALE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaud...

19 new deals announced in the month of July. Thoma Bravo acquires Medallia. Aon and Willis Towers Watson terminated their business combination agreement. For further details see: Merger Arbitrage Mondays - Thoma Bravo Announces 2 Large Deals In A Single Month ...

Gainers: ERYTECH Pharma (NASDAQ:ERYP) +84%, Allied Healthcare Products (NASDAQ:AHPI) +31%, SCWorx (NASDAQ:WORX) +18%, Veracyte (NASDAQ:VCYT) +13%, Misonix (NASDAQ:MSON) +11%. Losers: Intec Pharma (NASDAQ:NTEC) -20%, Translate Bio (NASDAQ:TBIO) ...

Bioventus (NASDAQ:BVS) expects Q2 prelim net sales to be in the range of $108 to $110M represents 86.2% to 89.7% Y/Y. Analysts consensus estimates for Q2 net sales stands at $97.64M. The sales comprises of net sales from legacy Bioventus of $96.5 to $98M (+66.4% to 69% Y/Y) and net sales...

Significantly Expands TAM and Adds Considerable Scale and Scope in Spine and Lower Extremity Enhances Surgical Solutions Vertical by Adding Minimally Invasive Ultrasonic Technologies That Improve Clinical Outcomes Deepens Restorative Therapies Vertical by Adding Regenerati...

FARMINGDALE, N.Y., July 29, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes today announced prelim...

DURHAM, N.C., July 29, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported preliminary financial results for the three months ended July 3, 2021. Preliminary Second Quarter Net Sale...

The following slide deck was published by Misonix, Inc. in conjunction with this event. For further details see: Misonix (MSON) Presents At UBS Global Healthcare Virtual Conference 2021 - Slideshow